Jorge Acevedo, MD
Orthopaedic Surgery · Jacksonville, FLNPI 1710969225
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $2,640,765 of the $3,273,191 with a category attached, or 80.7%. Arthrex accounts for 99.8% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $721,993, 2.4 times the $296,787 reported in 2019. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 633 payments — averaging $5170.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3.3M
- Team 1, LLC$4K
- Medline Industries LP$1K
- Stryker$593
- Integra Lifesciences Corporation$286
- Amgen$255
- plus $955 from 18 others
Across 1 payment — averaging $4500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$5K
What the payments were for
- Royalty or licence$2,640,76581%
- Consulting fees$150,9405%
- Speaking & faculty fees$416,74913%
- Travel & lodging$54,8052%
- Food & beverage$7,6430%
- Education$2,0130%
- Gifts$950%
- Other$1810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 565 | $3,265,897 |
| Team 1, LLC | 5 | $3,840 |
| Medline Industries LP | 7 | $1,364 |
| Stryker(2 entities) | 5 | $593 |
| Integra Lifesciences Corporation | 3 | $286 |
| Amgen | 17 | $255 |
| Alpha Orthopedic Systems | 3 | $166 |
| Exactech, Inc. | 1 | $154 |
| Johnson & Johnson | 7 | $138 |
| Mimedx Group, Inc. | 1 | $113 |
| Heron Therapeutics, Inc. | 3 | $56 |
| Boehringer Ingelheim | 2 | $52 |
| Treace Medical Concepts, Inc. | 1 | $45 |
| Abbott | 2 | $41 |
| Zimmer Biomet | 2 | $38 |
| Smith+Nephew | 1 | $25 |
| Paragon 28, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Molnlycke Health Care US, LLC | 1 | $18 |
| Convatec Inc. | 1 | $17 |
| Innovation Technologies Inc | 1 | $15 |
| Bioventus LLC | 1 | $13 |
| Zimvie Inc. | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$11,730,444
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ANCHORS$295,206
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE IB LIGAMENT AUGMENTATION$294,706
- KNEE & HIP IMPLANTS OTHER COLLATERAL LIGAMENT$294,706
- DISTAL EXTREMITIES INSTRUMENTS DEVICE SPECIFIC INSTRUMENTS HINDFOOT & ANKLE$210,361
- DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE CALCANEUS$209,861
- DISTAL EXTREMITIES INSTRUMENTS TRAUMA HINDFOOT & ANKLE TRAUMA$84,845
- DISTAL EXTREMITIES IMPLANTS TRAUMA CALCANEUS$84,845
- DISTAL EXTREMITIES IMPLANTS COMPRESSION SCREWS METAL COMPRESSION SCREWS$5,250
- DISTAL EXTREMITIES INSTRUMENTS MIS SU BURRS$2,500
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ACHILLES$2,101
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE SPEEDBRIDGE$1,250
- DISTAL EXTREMITIES IMPLANTS TRAUMA PATELLA FRACTURE$500
- PROPHECY$292
- DISTAL EXTREMITIES IMPLANTS IB LIGAMENT AUGMENTATION OTHER$250
- INTEGRA$181
- ORTHOLOC 3DI$171
- VANTAGE$154
- DISTAL EXTREMITIES INSTRUMENTS FOOT & ANKLE MIS DISPOSABLES$136
- DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE TTC NAIL$126
How this compares
$3,273,191 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcipotriene | 20 | $4,398 |
| Lidocaine | 83 | $3,644 |
| Ciclopirox | 32 | $3,202 |
| Meloxicam | 118 | $721 |
| Ketoconazole | 14 | $212 |
| Gabapentin | 22 | $161 |
| Celecoxib | 24 | $158 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Jacksonville
- Bryan SpringerJacksonville$6.3M
- Rahul DeshmukhJacksonville$769K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.